Medicines for Children - Information for Healthcare Professionals, Children & their Carers
The ICCPE session at the Pharmaceutical Society of Ireland Conference in
October expanded on the theme of Medicines for Children, which was the
subject of the Centre's highly successful national training initiative
in spring. Introducing the event, ICCPE Director, Ms. Orla Sheehan,
outlined the outcomes of this training initiative and its aim "to try to
promote an ethos of child-centred care." "Today is all about building
on that initial strategy," Ms. Sheehan said.
Mr. Ian Costello, Senior Editor of the BNF for Children (BNFc)
outlined the arduous process involved in the collation and publication
of this newly published formulary. "The biggest challenge we faced was
making it relevant to all healthcare professionals in primary care,
secondary care and tertiary care," Mr. Costello said. In previous
paediatric formularies, he noted that "there were lots of contradictions
and inconsistencies that we had to resolve."
The collation of the BNFc involved the work of four collaborators:
the Neonatal and Paediatric Pharmacists Group (NPPG), the Royal College
of Paediatrics and Child Health (RCPCH), the Royal Pharmaceutical
Society of Great Britain (RPSGB) and the British Medical Association
(BMA). Similar to its distribution of the BNF, the British Department
of Health has purchased the BNFc and made it available to every
prescriber and pharmacist in the UK.
As well as the provision of standard information on drugs used in
children, clear indications of the licensing status for each drug and
recommendations on when specialists should supervise, manage or
prescribe a particular treatment, the BNFc has brought a lot of
information from the pharmaceutical industry into the public domain.
Mr. Costello refers to this newfound access to previously unavailable
information as "one of the side effects of this process."
BNFc will be revised and published every year and an online version
is also available. Ian Costello pointed to the fact that a lot of new
information is emerging in the area of medicines use in children. "The
BNFc will be the conduit for emerging information," he said.
Professor Pat Bush of Georgetown University School of Medicine,
Washington, first started conducting research on medicines and children
in the early 1980s and was one of the earliest pioneers of
child-friendly information on medicines. At this time, she noted that
"The slogan 'don't do drugs' was everywhere. But this common activity
that they [children] see every day of their lives - no-one was teaching
them about it." Throughout the 1980s and 1990s, Professor Bush
formulated a wide body of research in this area in the United States and
performed comparative studies in 10 European countries, in Armenia,
Malaysia and Nepal. As she noted, the results among the countries
surveyed were enough to show that "not every country has to start de
novo. You can take existing educational materials and adapt them for
your own country."
As a visiting scholar with the U.S. Pharmacopeia, Professor Bush
directed the Children and Medicines Programme (available at www.usp.org/audiences/consumers/children/)
and developed the Ten Guiding Principles for Teaching Children and
Adolescents About Medicines. In her presentation, she stated that
people's "feelings, beliefs and attitudes are being formed at a very
early age. You can't wait 'til they're older to inform them about
medicines." She pointed out that medicines education must be taught
"gradually at the appropriate time, at the appropriate development
level."
A performance by Doctor Merry-Go-Round and Doctor Fairy-Dust, Clown
Doctors with the Humour Foundation of Ireland provided a playful
interlude to proceedings. The Humour Foundation's aim is to promote the
health benefits of humour by making the hospital experience less
traumatic for children. It currently provides a Clown Doctor service in
Crumlin Hospital with the aim of developing similar services in
hospitals throughout the country.
Ms. Katrii Hameen-Anttila from Finland and Dr. Natalia Cebotarenco
from Moldova each outlined innovative programmes which have been
developed in their respective countries to provide medicines education
to children. Ms. Hameen-Anttila outlined how the National Curriculum
for Health Education (2004) has made the provision of medicines
information a compulsory aspect of the health education programme
provided in Finnish schools and the research that shaped the development
of teaching materials. Dr. Cebotarenco presented the outcomes of a
Moldovan project which sought to reduce unnecessary antibiotic use for
colds and flu. A school-based programme was developed and delivered by
fifty teenagers who presented six lessons to their classmates on
appropriate treatments for colds and flu.
An Irish context for medicines information for children was given by
Ms. Frances Foley, who is currently undertaking a research project on
children's perceptions of medicines and the development of
child-friendly educational materials as part of an MSc. in Community
Pharmacy. To date, her research has included focus group discussions in
two primary schools to gauge children's levels of knowledge about and
their experiences of taking medicines. A series of drawings created by
these schoolchildren gave an interesting and diverse insight into
children's perceptions of illness and medicines. Ms. Foley will
continue this research by surveying parents, teachers and pharmacists.
She concluded the day's presentations with the following advice for
pharmacists when dealing with children: "We need to come out from behind
the counter. We need to get down on our knees - not to pray for higher
margins - but to look the customers of tomorrow in the eye and engage
with them."
Julie Cronin